RxDoctor Payments Data

Peter Neglen

Vascular Surgery · Flowood, MSNPI 1518990720

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $363,972 of the $598,582 with a category attached, or 60.8%. Boston Scientific accounts for 95.9% of it on its own, with 1 other manufacturer making up the rest. Among vascular surgery clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$598,582in general payments, 2019–2025

Across 9 payments — averaging $66,509 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$574K
  • Veniti, Inc.$25K

What the payments were for

  • Royalty or licence$234,61139%
  • Ownership interest$363,97261%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific8$573,813
Veniti, Inc.1$24,769

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$598,582 in reported general payments places this provider in the 95th percentile of 39 vascular surgery providers in Mississippi.

See all vascular surgery providers in Mississippi →

Other vascular surgery in Flowood

See the full list for Mississippi →

Where these figures come from

Is this you, or does something look wrong? →